about
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoproteinRole of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomyIn silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.Adsorption of human papillomavirus 16 to live human sperm.Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.Genetic susceptibility to HPV infection and cervical cancer.Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretionsMicroarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of miceMechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa.Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model.Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes.Human papillomavirus infections: epidemiology, pathogenesis, and therapy.Apoptotic HPV positive cancer cells exhibit transforming properties.Men's reproductive and sexual health.Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.Abnormal cervical cytology in bone marrow transplant recipients.Oncogenic human papillomavirus genital infection in southern Iranian women: population-based study versus clinic-based dataInterleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells.HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.The causes and prevention of cancer: gaining perspective.Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.Viral carcinogenesis: factors inducing DNA damage and virus integrationListeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection.The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitroHuman papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.Intratype variation in 12 human papillomavirus types: a worldwide perspective.Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.The Dynamics of HPV Infection and Cervical Cancer Cells.Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activityChimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.Vaccination strategies for the prevention of cervical cancer.Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia
P2860
Q24294963-3355BBF4-A382-4C61-AAAE-F1F476B8FCBAQ24309432-B400A7FD-B35C-44E2-A0ED-276DCB51AAC6Q24314673-B8876859-42B8-4628-BA75-F1FB52203867Q28775735-3E50CFBA-FF81-4233-ADD5-08AACD241EC8Q30661799-8F9AB89A-A98D-404A-84E5-01A012D806EBQ33464965-84868A85-A81B-4818-9AAE-E0456E54B68DQ33707499-11D8894B-2F1D-4FE1-88CB-EF42F3CC5312Q33716371-D4FD538E-4CF5-4093-BDE2-16B3F576B4C2Q33784891-255E6E8D-04D7-47B1-8928-1FE02C3D70C2Q33803580-601D42CB-3A71-4BC4-BCFC-925393C19017Q33823755-04BFBD38-9055-4180-95F1-60B595F42553Q33847326-3640EF37-8EE7-4A4C-BA34-0194E8BAD67BQ33874465-33C731AF-6666-4CCA-8BFE-61DF13C4DB2DQ34069364-C8863077-2D58-46DA-9336-795384716133Q34147515-875F559B-CD3D-44B2-B22C-3E54B64360BEQ34204141-94A0A99A-DD98-4E3B-A436-FC584162880FQ34264940-630A0D23-942F-4A0B-B227-02EBFA44ED63Q34286762-C0DF04BA-37FA-404A-80DD-933B1AC9314CQ34361895-D00035EB-FF65-49AD-ABB2-AC995817E0BAQ34380742-D704A812-8642-4D2E-94C8-A4CDEEBF3A28Q34411356-D2C0613E-3E23-47AE-8D13-FF6D001A0A7BQ34508216-13344D9B-5C4C-46F5-AC0C-1ED8A0904603Q34566683-E7111645-6210-4A7D-A310-E4F2088E652AQ34638943-0ED65358-65D7-4EA9-B149-361AC0243F7AQ34757163-7DAB7C41-44F8-4F2A-9A92-D83035F91DF6Q34774880-4F49AC32-0742-4195-931F-3EABC4C8D954Q34797653-F4D186F8-8405-4447-B0BE-A0BAE6C312D5Q35553171-939E7606-4841-4396-BBB4-1E9AC47AF259Q35562265-E5ACAD7E-2919-44F4-A211-628BB2861B90Q35690884-CEE03737-F7CE-42EC-A65E-94A32725900FQ35782743-EFD143D4-51B3-48A7-AF7B-F9B9F4499968Q35795051-26BF33C6-7C1C-4BEA-BFF1-D764C7BCD5AAQ35852125-7A7E3792-F3B2-498F-9A8A-163CEAA60142Q35860444-A7325C1A-FD52-4057-A410-A7949D56F210Q35860748-F9EB5B4A-E75C-4E4B-9354-CB88485D2B4BQ35871191-500082EA-E7DC-40D0-A075-9F443F07E2A9Q35888709-BD8DA935-24FB-4067-8BB9-5AC3A0691CDCQ35891225-4A0B2379-0B91-4972-939A-A590004C2811Q36066161-2719B2AA-B9B3-49DF-9DFA-1B9E5F2114C3Q36114121-703A1DB1-89FA-4892-A3BE-2C81491C47B1
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Genital human papillomavirus infection
@ast
Genital human papillomavirus infection
@en
type
label
Genital human papillomavirus infection
@ast
Genital human papillomavirus infection
@en
prefLabel
Genital human papillomavirus infection
@ast
Genital human papillomavirus infection
@en
P2093
P2860
P356
P1476
Genital human papillomavirus infection
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.7.2436
P407
P577
1994-03-01T00:00:00Z